| 0.69 Data as of 3:59pm ET |  -0.005 / -0.72%Today’s Change | 0.62 Today|||52-Week Range 1.38 | -10.39% Year-to-Date |
| Previous close | 0.70 |
| Today’s open | 0.71 |
| Day’s range | 0.66 - 0.71 |
| Volume | 119,727 |
| Average volume (3 months) | 383,652 |
| Market cap | $17.4M |
| Dividend yield | -- |
| Earnings growth (last year) | +50.00% |
| Earnings growth (this year) | +46.67% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 173.88 |
| Price/Book | 1.37 |
| Today’s change | Today’s % change | |
|---|---|---|
| NVGNNovogen Ltd | -0.10 | -2.38% |
| --Targeted Medical Pha... | +0.12 | +18.30% |
| TZYMTranzyme Inc | -0.01 | -2.37% |
| MSTXMast Therapeutics In... | -0.00 | -0.23% |
| Last reporting date | June 18, 2013 |
| EPS forecast (this quarter) | -$0.11 |
| Annual revenue (last year) | $53.6K |
| Annual profit (last year) | -$7.3M |
| Net profit margin | -13,632.61% |
Sector Health Technology |
Industry Medical Specialties |
President, Chief Operating Officer & Director Christopher G. Clement |
Director, Chief Executive & Medical Officer David J. Drutz, MD |
Corporate headquarters Raleigh, North Carolina |
.
